logo
Mental Health Held Hostage Behind Bars

Mental Health Held Hostage Behind Bars

Medscapea day ago

This article launches a new series on prison psychiatry, produced in collaboration with Univadis Italy , a Medscape Network platform. All the published articles are grouped on an exclusive page and updated over time.
Every time a violent incident involving an inmate with a mental illness creates headlines, it tends to overshadow the work of correctional mental health professionals. This was the case at Bollate Prison near Milan, Italy, where an inmate on semi-liberty fatally stabbed one coworker, seriously injured another, and died by suicide after jumping from the Duomo terrace. Although convicted of homicide in 2016, the patient showed no overt psychiatric symptoms. However, a former fellow inmate later claimed that he exhibited signs of distress in an article published in Il Manifesto.
System Reform
This tragic story is part of the broader context of mental health protection in prisons, which has evolved since the 2008 reform that transferred responsibility for inmate healthcare from the Ministry of Justice to the Ministry of Health. The reform culminated a decade ago in the final closure of judicial psychiatric hospitals nearly 50 years after Franco Basaglia's landmark 1978 reform, which abolished all psychiatric hospitals in Italy.
'Integrating prison healthcare into the national health system took years, but it introduced the concept of clinical responsibility — so inmates are treated as patients,' said Antonella D'Ambrosi, a psychologist who has worked in Italian prisons since 1996, to Univadis Italy .
Since 2020, she has led the Dependencies and Psychopathology Unit in the Frosinone Penitentiary Institutions, primarily intended for the custody of people awaiting trial and for the execution of prison sentences of < 5 years), and a prison (a penitentiary institution intended for those definitively sentenced to medium-long prison sentences, generally > 5 years).
A 2019 Constitutional Court ruling confirmed this paradigm shift, affirming that all citizens, including prisoners, have the right to physical and mental healthcare.
Psychiatric Prevalence
However, despite these reforms, overcrowding remains a serious problem. By the end of 2024, 62,153 people had been detained in Italy — approximately 2000 more than in 2023 — against an official capacity of around 47,000.
In San Vittore, Milan, the actual overcrowding has reached 225%; in Brescia Canton Monbello, 205%; in Como and Lucca, 200%; in Taranto, 195%; and in Varese, 194%, the report stated. 'There are now 59 institutions with an overcrowding rate higher than 150%, mainly the large metropolitan prisons, those with the highest number of admissions and the greatest tensions.'
Mental illness is far more common in the prison population than in the general population.
A 2015 study in the journal Psychiatry Research of 300 inmates in Cagliari found that 58.7% had a psychiatric disorder compared to 8.7% in healthy individuals. Another 2016 epidemiological study of 15,751 inmates across 57 facilities in six regions of Italy found that 67.5% had at least one clinical diagnosis. Of them, 41.3% (27.9%) had a psychiatric diagnosis. Other common health conditions included gastrointestinal disorders (14.5%), infectious diseases (11.5%), cardiovascular diseases (11.4%), endocrine, metabolic, and immunological disorders (8.6%), and respiratory illnesses (5.4%).
Parma Initiative
Another in-depth investigation into prison mental health was conducted in Parma by Lorenzo Pelizza, MD, PhD, a professor at the Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. He began working in the prison system by chance and returned to his hometown for family reasons. 'When I asked for a transfer, they told me, 'We are happy to have you, but you will need to work in the prison — no one else wants to go there,'' Pelizza told Univadis Italy . 'I agreed.'
A few months after his arrival, the team leader left for another position, and Pelizza was offered this role. 'I found myself working with many non-health professionals inside the prison — security personnel, social workers, and educators — and I kept hearing the same concern: The psychiatrist's hours needed to increase. Thus, there is a clear need for psychiatric support. Therefore, data were gathered to better understand these needs, particularly in relation to the types of diagnoses.
The idea of this study was simple: To systematically assess all new inmates upon entry, including transfers from other institutions, and then follow them for 1 year. The rollout was delayed by the COVID-19 pandemic; however, despite concerns regarding contagion, this study continued. 'We evaluated about 400 admissions ourselves, using consistent diagnostic criteria,' Pelizza said. 'We found that the main issue, affecting more than half of the cases, was addiction.'
Among the psychiatric needs, most disorders are linked to depression and anxiety, which are often driven by detention. 'We classify these as adjustment disorders, which can sometimes present with significant depressive symptoms,' he explained. 'Serious mental disorders — the kind typically managed by community mental health services — made up only about 10% of cases.'
The findings, according to Pelizza and colleagues, challenge the common perception that more psychiatrists are urgently needed in prison, except for medication prescriptions, for which they caution that it is not always appropriate.
The findings revealed that 63.1% of the inmates received at least one anxiolytic prescription, 20.3% received antidepressants, and 19.9% received antipsychotics. One third of the inmates received at least one psychiatric consultation during detention, averaging 1.4 visits per inmate per year.
'Even the visits we doctors make outside of prison often lead to a prescription of drugs because this is what the patient expects. This also occurs in prisons, where the request for drugs is often excessive compared to needs, and not only in cases of addiction. Prescriptions often have the purpose of reassurance and sedation to immediately deal with a new situation. In many cases, it could be possible to reassure even by listening to the needs of prisoners who are not strictly medical,' Pelizza said.
Intake Stressors
These stressors are countless, especially in remand prisons, where many inmates await sentencing in a state of extreme uncertainty. 'There are people who are suddenly taken into custody and thrown into prison with no warning. They arrive without a suitcase, without a change of clothes — completely unprepared,' Pelizza explained. 'They sit in their cells, not even understanding where they are. They don't know the rules, how to request basic items, or how to get in touch with their families.'
Pelizza vividly recalled one case: A Swedish man in his early twenties who was arrested on the highway while riding in a taxi that he had taken from Bologna to Milan. Previously, he had attempted to steal a woman's car by grabbing her. The attempt failed, and he fled, but the woman was injured when she fell during the incident.
'When the boy arrived in prison, his mental state was completely altered. Only after a few days were we able to get him to tell his story — in English because he did not speak Italian — and we concluded that the trip he had suddenly decided to take to Italy was already linked to an alteration in his mental state, probably a manic phase in a bipolar disorder,' Pelizza recalled.
'In addition to trying to start a treatment inside, I was concerned with building an alternative path outside the prison, since, among other things, he was in pretrial detention. It took 3-4 months, but we managed to bring him to our residence in Parma, where he remained for almost a year, until the trial,' continued Pelizza.
At trial, the young man was deemed unfit to stand trial because he was incapable of understanding or intending his actions at the time of the crime. He was released after being judged no longer to be in danger to himself or others, thanks to the therapy he had undergone in the interim. 'This is a classic example: In prison, he could not have been treated, whereas in the residential facility, he received care and experienced no further clinical relapses,' Pelizza concluded.
Residence for the Execution of Security Measures (REMS) Network
The Parma experience is also unique in many ways, not only because of the high standards of Emilia Romagna's public health system but also because the same Department of Mental Health that operates within the prison oversees two therapeutic communities for the general population and a REMS. REMS facilities, introduced in the 2015 reform, replaced old judicial psychiatric hospitals (OPGs). They are intended for individuals who commit crimes but are deemed not prosecutable due to mental incapacity at the time of the offence — people who cannot simply return home because they may pose a danger to themselves or others.
Currently, there are 32 REMS facilities in Italy. Each region is required by law to have at least one, although Calabria and Umbria have yet to establish their own. In total, 630 locations are available, as each REMS is legally limited to a maximum of 20 beds. An exception exists at Castiglione delle Stiviere, once home to the last remaining OPG, where 160 patients are housed, although they are formally divided into eight separate REMS units.
Capacity Challenges
According to a document approved in February 2025 by the Superior Council of the Judiciary, around 700 individuals meet all the criteria for transfer to an REMS but are still waiting for a place — 45 of them are currently held in prison. The Ministry of Health has opposed the creation of additional REMS facilities, citing the principle summarized in the CSM report : 'The more containers there are, the more they are filled.' However, the ministry is still evaluating the possibility of increasing the total number of places by 20%.
Giuseppe Nese, MD, is the director of the Multispecialty Department for Prison Health Services, Local Health Authority (ASL) Caserta; he also serves as the coordinator of the Regional Inter-Institutional Group for Prison Mental Health and Secure Psychiatric Care (REMS) in the Campania Region, which oversees four prison facilities, including a REMS, and has long collected and analyzed data to assess psychiatric needs. He believes that the current number of REMS places is sufficient and argues that a cultural shift across the entire system is needed. Despite the closure of the OPGs, he said that courts continue to favor detention, even though the spirit of the reform law is to reintegrate into society those who can be treated within the regular healthcare system.
'There is a widespread tendency in Italy to assign patients subject to temporary security measures to REMS,' noted the Antigone Association's report on REMS, edited by Nese. 'Yet the law stipulates that such measures should be applied only when alternative options are inadequate in addressing both clinical needs and potential social risk.' He also pointed out that both the European Court of Human Rights and Italy's Constitutional Court have repeatedly emphasized the need to find alternatives to forced hospitalization — whether in former OPGs or REMS — stressing the importance of balancing care with public safety.
A common scenario, he explained, is that of a person who commits a serious crime without any apparent mental illness, only for psychiatric issues to emerge after their incarceration. 'Sometimes it becomes clear that the individual may have committed the offense while mentally incapacitated,' Nese told Univadis Italy . 'In such cases, even before sentencing, a judge can order the provisional application of a security measure in a REMS. However, the judge must also assess whether that person, though deemed not legally responsible due to mental illness, is socially dangerous. If they are not, no security measure should be applied.'
In essence, if a person is not considered a danger to society, they should remain in prison only if there is a risk of escape or reoffending. Otherwise, they await trial in freedom. However, Nese noted that this critical evaluation often arrives too late in the judicial process.
The challenges of mental healthcare in the prison system in Italy are also evident in the numbers — numbers that appear high for another reason linked to the legal assessments that determine criminal responsibility. According to Nese, approximately 1 in 5 people on the REMS waiting list would not be eligible for admission as they are involved in more than one legal proceeding. It is not uncommon for someone to be deemed not criminally responsible in one case but responsible in another based on differing psychiatric evaluations.
A promising initiative launched approximately 18 months ago in Ficarolo, Veneto, on the border with Emilia-Romagna and Lombardy, aimed to ease REMS waiting lists, reduce inconsistencies in psychiatric assessments, and improve the appropriateness of care. Psychologist Stefano Rambelli explained that the Criminological Profiling and Analysis Center (CePAC) is a facility dedicated to the observation and assessment of individuals with psychiatric disorders who have committed crimes.
The multidisciplinary team at CePAC, a private facility accredited by the National Health System, assists court-appointed experts by observing individuals, up to a maximum of 20 at a time, over several months.
In some cases, these individuals return to prison, where the most severe psychiatric cases are managed in specialized units known as ATSM (mental health protection units). These sections provide more continuous medical care, and inmates often participate in group activities during the day, although they return to their cells at night. Currently, 32 ATSM units operate within 17 penitentiary institutions, one per region, housing approximately 300 prisoners with serious mental health conditions.
'The shift to REMS created parallel systems of care, but the overall response remains inadequate,' said Ines Testoni, PhD, a professor of social psychology at the University of Padua, Padua, who has conducted extensive research on prison mental health and suicide prevention. 'Many people with psychiatric conditions still end up in prison, where they cannot be properly managed.' Suicide is a sentinel event, an extreme signal of unmanageable psychological distress.
Estimates of suicide in prisons vary depending on the source. According to the National Guarantor for the Rights of Persons Deprived of Liberty, which compiled data from penitentiary authorities, there were 83 suicides in 2024, compared to 68 in 2023 and 84 in 2022. However, Ristretti Orizzonti, a long-standing publication by inmates at Padua Prison, reported that 2024 saw 91 suicides. The magazine also estimated that total prison deaths from all causes reached an unprecedented 246 in 2024, up from 241 in 2023 and 212 in 2022.
The psychological toll extends beyond inmates. 'Prison staff face the difficult task of balancing punitive, rehabilitative, and therapeutic roles, creating conflicting expectations and emotional strain,' Testoni explained. She has also studied suicides among prison officers, for whom it is difficult to obtain reliable data. According to Ristretti Orizzonti, 148 prison officers died by suicide between 1997 and 2018.
Testoni led a qualitative study involving focus groups and semi-structured interviews with staff at eight prisons in northeastern Italy. The goals were to understand their perspectives, identify systemic challenges, and explore the need for more collaboration with external services. This study also highlights the urgent need for enhanced training, greater staffing, and improved infrastructure.
'We need to invest in radically new solutions, which currently do not exist. Whenever a mental health issue emerges in prison, external care pathways must be available, even for those already convicted. For prison officers, we must create opportunities for them to process the relational and emotional challenges they face, free from stigma. Mental illness is a kind of 'contagious' suffering,' Testoni concluded.
Testoni also emphasized that community doctors should pay close attention to the mental health of people who have been in prison or work there.
Fabio Turone is an Italian science journalist, founder of Agenzia Zoe, president of the Science Writers of Italy, and a board member of the European Federation for Science Journalism. He has reported for the BMJ , Nature , and Research Professional and was a 2016-2017 Knight Science Journalism Program Fellow at Massachusetts Institute of Technology, Boston.
Chiara Sabelli earned a PhD in particle physics in 2012 and later completed a master's in science communication at the International School for Advanced Studies in Trieste. She has worked in science communication since 2017 and has been a journalist since 2019. She contributes to Nature Italy and Scienza in Rete.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RCGP Urges Support to Save Declining GP Partnership Model
RCGP Urges Support to Save Declining GP Partnership Model

Medscape

time28 minutes ago

  • Medscape

RCGP Urges Support to Save Declining GP Partnership Model

The Royal College of General Practitioners (RCGP) has warned that GP partnerships are under threat, as the number of partners in England has dropped by 25% over the past decade. In a new report, the college urged action to 'break down barriers to partnership' and called for modernisation of the model to make it more attractive to younger doctors. While the RCGP reaffirmed its support for the independent contractor model, it said there was 'room for modernisation and innovation', and backed ' a mixed economy' of contractual models to deliver general practice. Shift in Workforce Between 2015 and 2025, the number of GP partners in England fell from 24,491 to 18,367. Over the same period, the number of salaried GPs rose by 81%, from 10,270 in September 2015 to 18,557 in December 2024. As of June 2024, GP partners were a minority among fully qualified GPs for the first time. The most significant drop in partnership was seen in younger doctors. Among GPs aged 30-34, numbers fell by 72.9%. The only age group to show growth was those aged 60-64, up by 19.5%. Barriers to Partnership Rising workload, administrative burdens, and concerns about financial risk were cited as major deterrents to partnership. Professor Kamila Hawthorne, RCGP chair, said that many GPs were discouraged by the unlimited personal liability that comes with being a partner. She also pointed to the responsibilities of owning or leasing premises and managing staff, especially as patient demand increases. Exploring Alternatives The RCGP report explored alternative business models that could support general practice, including limited companies, limited liability partnerships (LLPs), and community benefit societies. The college maintained that partnerships still offered flexibility and potential for innovation, particularly if financial and workload pressures could be reduced. In 2024, more than half (55%) of RCGP members said they would be more likely to consider partnership if financial risks were lower. A review by Lord Darzi highlighted the financial discipline of GP partnerships, noting that they could not run large deficits like other parts of the NHS. Earlier this year, the Nuffield Trust described the current GP partnership model as 'withering'. The health think tank warned that the government's plans to improve GP access were at risk due to the fall in partner numbers. Thea Stein, chief executive of the Nuffield Trust, told Medscape News UK : 'It is hard to see partnership being the dominant model in the future.' She called for support where the model works well, but said new models must also be explored. Hawthorne maintained that 'there are elements of the traditional GP partnership that can be improved and modernised, while retaining its core strengths'. The GP partnership model has huge benefits for the NHS and for patients, she added. Government Response A Department of Health and Social Care (DHSC) spokesperson acknowledged the strengths of the partnership model, including efficiency, innovation, and continuity of care. 'However, we also recognise that this is not the only model delivering general practice,' the spokesperson told Medscape News UK . 'GP practices can choose to organise themselves in different ways and also provide good outcomes in terms of staff engagement and patient experience.'

Hematologists Set the Stage for Market Disruption as Next-Gen Hemophilia Therapies Gain Traction
Hematologists Set the Stage for Market Disruption as Next-Gen Hemophilia Therapies Gain Traction

Associated Press

time39 minutes ago

  • Associated Press

Hematologists Set the Stage for Market Disruption as Next-Gen Hemophilia Therapies Gain Traction

EXTON, PA, June 12, 2025 (GLOBE NEWSWIRE) -- As the hemophilia landscape continues to transform, new research from Spherix Global Insights reveals a market on the cusp of significant evolution driven by innovation, physician receptivity, and an increasingly nuanced approach to patient care. The latest Market Dynamix™: Hemophilia (EU) 2025 report, based on feedback from 160 hematologists across the UK, France, Germany, Italy, and Spain, illuminates shifting treatment preferences and the widening role for advanced therapeutic options across hemophilia A and B. The study captures a broadening treatment mindset in a market historically dominated by factor replacement therapies. Although conventional agents have provided stability for many patients, Spherix data highlight an increasingly urgent unmet need, particularly among patients with inhibitors. In fact, patients with inhibitors represent the group for whom hematologists see the greatest opportunity for innovation. Products such as Alhemo (Novo Nordisk) and Qfitlia (Sanofi) are already entering the physician consciousness as promising options, with early prescribing experiences for Alhemo in Germany showing favorable clinical feedback. Importantly, European hematologists are signaling readiness to embrace novel mechanisms that deliver sustained efficacy and reduce treatment burden. Beyond Alhemo and Hympavzi, there is rising anticipation for agents like Qfitlia and Mim8 (Novo Nordisk). Gene therapy, once seen as aspirational, is becoming a more realistic consideration, especially in hemophilia B where therapeutic alternatives remain limited. CSL Behring's Hemgenix and BioMarin's Roctavian are drawing interest, albeit tempered by concerns around cost and long-term outcomes. Spherix data reveal a market increasingly driven not just by efficacy but by lifestyle alignment and convenience. This reflects a maturation of brand expectations, where baseline efficacy is presumed and differentiation hinges on quality-of-life enhancements. The move away from standard half-life (SHL) and even extended half-life (EHL) products is evident, particularly in hemophilia A, where agents like Hemlibra (Roche/Genentech) and Altuvoct/Altuviiio (Sanofi) are rapidly becoming standard practice. Underlying these trends is a broader shift in therapeutic philosophy: goals focus less and less on symptom control (which is assumed) while disease modification becomes centrally important, mirroring changes seen in other chronic specialty markets. Hematologists are prepared to make transitions, especially when options can seamlessly accommodate inhibitor development without requiring treatment change. For Hympavzi, Alhemo, and Qfitlia, upcoming Launch DynamixTM tracking among US hematologists (available June 13th) underlines similar themes, with projected prescribing steadily rising for these novel agents. Additional metrics included in launch tracking include impact of product features and manufacturer programs on prescribing, assessment of likely patient groups for initial product trialing, and perspectives on which brand(s) are likely displaced by newer market entrants. Ultimately, as the treatment paradigm continues to evolve, biopharma stakeholders seeking success in the hemophilia space will need to align not only with clinical outcomes but also with patient-centric attributes now prioritized in physician decision-making. Market Dynamix™ is an independent service providing analysis of markets anticipated to experience a paradigm shift within the next three to five years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents. Launch Dynamix™ is an independent service providing monthly benchmarking of newly launched products for the first eighteen months of commercial availability, augmented by a quarterly deep dive into promotional activity, barriers to uptake, and patient types gravitating to the launch brand. About Spherix Global Insights Spherix is a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry, across the brand lifecycle. The seasoned team of Spherix experts provides an unbiased and holistic view of the landscape within rapidly evolving specialty markets, including dermatology, gastroenterology, rheumatology, nephrology, neurology, ophthalmology, and hematology. Spherix clients stay ahead of the curve with the perspective of the extensive Spherix Physician Community. As a trusted advisor and industry thought leader, Spherix's unparalleled market insights and advisory services empower clients to make better decisions and unlock opportunities for growth. To learn more about Spherix Global Insights, visit or connect through LinkedIn. For more details on Spherix's primary market research reports and interactive dashboard offerings, visit or register here: NOTICE: All company, brand or product names in this press release are trademarks of their respective holders. The findings and opinions expressed within are based on Spherix Global Insight's analysis and do not imply a relationship with or endorsement of the companies or brands mentioned in this press release. Sarah Hendry, Hematology Franchise Head Spherix Global Insights 4848794284 [email protected]

Family Dinners, Stronger Social Ties Boost Teen Sleep
Family Dinners, Stronger Social Ties Boost Teen Sleep

Medscape

timean hour ago

  • Medscape

Family Dinners, Stronger Social Ties Boost Teen Sleep

Strong family ties and in-person social connections may contribute to healthy sleep in adolescents. COVID-era survey data from nearly 5000 preteens showed that gathering around the family dinner table and participating in neighborhood activities predicted longer sleep duration, while family conflict, household distancing, and longer time spent with technology predicted shorter sleep time. 'Social connectedness is tightly linked with mental and emotional health: Healthy, regular, in-person social connections, including parental monitoring, are known to favor well-being in adolescents,' lead author Marie Gombert-Labedens, PhD, with the Biosciences Division, SRI International, Menlo Park, California, told Medscape Medical News . 'Through routine and structure, reduced conflicts and associated stress, and lower screen-related stimuli, these relationships may contribute to foster a healthy sleep environment. In parallel, adequate sleep durations allow teens to be in better mental and emotional disposition, which may also lead to positive social connections, said Gombert-Labedens. The findings were presented on June 11 at SLEEP 2025 in Seattle. Better Sleep, Real-Life Bonds COVID lockdowns and distancing measures led to significant disruptions in adolescents' social interactions, altering the quality, quantity, and type (in-person vs online) of social connections. The pandemic also affected sleep patterns, providing a unique opportunity to examine the relationship between social connectedness and sleep, the study noted in the conference abstract. They analyzed data from 4996 boys and girls aged 9-11 years from the Adolescent Brain Cognitive Development Study who completed at least two COVID-19 surveys — the first in May 2020 and the second in August 2020. At both timepoints, family conflict, household distancing, and longer use of technology-mediated connections were associated with a higher probability of short sleep. Conversely, eating dinner with family and participating in neighborhood activities predicted longer sleep. When analyzed in clusters of social connectedness, the lowest rates of adequate sleep and the highest sadness scores were robustly found in clusters characterized by high technology-mediated relationships or by poor family/friend relationships and little parental engagement. On the other hand, clusters characterized by high parental engagement, such as eating together and discussing plans for the following day, had significantly higher rates of adequate sleep and lower sadness scores. The results were adjusted for potential confounding factors including sex, age, race, and household income. Gombert-Labedens said that during adolescence, it's especially important to keep sleep top of mind — by asking about it and, when needed, trying strategies to create a healthier sleep environment. Social connections, within and outside of the family, may be a leverage toward better sleep, she said. This could include prioritizing in-person connections, providing routine and structure, including by monitoring and moderating technology use, and working on reducing conflicts and improving communication. Weighing in on the research journalist Lisa Lewis, MS, author of The Sleep-Deprived Teen , said a key aspect of the study is that it measured the impact of both in-person family relationships and online friendships on sleep duration. 'The study results reinforce the importance of family connectedness — specifically, adolescents' perceived closeness with their parents — on their sleep,' said Lewis, who wasn't involved in the study. 'It also reinforces that online relationships, while important, simply aren't a substitute for parental engagement and the effect it has on adolescents,' Lewis added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store